Showing posts with label positive. Show all posts
Showing posts with label positive. Show all posts
Factors that Promote Positive Adaptation to Stress and Adversity

Factors that Promote Positive Adaptation to Stress and Adversity

The phenomenon of resilience reflects positive adaptation despite contexts of risk, adversity, or trauma.

Factors that promote positive adaptation to stress and adversity include the following:

- self-esteem
- optimism
- internal control
- coping aimed at acceptance
- coping aimed at seeking emotional support
- social contacts



Tips for managing stress (2-minute BBC video):

- Take a few deep breaths
- Get plenty of exercise
- Socialize - don't stress alone, talk to someone and have a laugh
- Get out - go to the park

Read more: http://www.bbc.co.uk/scotland/brainsmart

References:

Psychological and Social Factors that Promote Positive Adaptation to Stress and Adversity in the Adult Life Cycle. M. Guadalupe Jiménez Ambriz, María Izal and Ignacio Montorio. Journal of Happiness Studies, 2011.

Positive thinking: 1-minute video advice from a Cleveland Clinic psychologist



Positive thinking. Stop thinking bad thoughts. Scott Bea, Clinical Psychologist, offers a simple solution to negative thoughts. He discusses how mindfulness encourages positive thoughts. Uploaded by ClevelandClinic on Apr 4, 2011.

Acyclovir reduces risk of HIV-1 disease progression, if positive for HIV-1 and HSV-2

Most people infected with HIV-1 are dually infected with herpes simplex virus type 2. Daily suppression of this herpes virus reduces plasma HIV-1 concentrations, but whether it delays HIV-1 disease progression is unknown.

In this study, the median CD4 cell count at enrollment was 462 cells per μL and median HIV-1 plasma RNA was 4 log10 copies per μL. Aciclovir reduced risk of HIV-1 disease progression by 16%.

The role of suppression of herpes simplex virus type 2 in reduction of HIV-1 disease progression before initiation of antiretroviral therapy warrants consideration.

References:

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. The Lancet, Volume 375, Issue 9717, Pages 824 - 833, 6 March 2010.
Image source: Diagram of HIV. Image source: Wikipedia.